| Issue |
Section |
Title |
File |
| Vol 31, No 2 (2020) |
Articles |
Current approaches to managing patients with acute liver failure |
|
| Vol 31, No 4 (2020) |
Articles |
Drug-induced hepatitis: clinical aspects |
|
| Vol 31, No 5 (2020) |
Articles |
Medications for COVID-19 prevention and therapeutic approaches during early-stage infection |
|
| Vol 32, No 12 (2021) |
Articles |
The features of a humoral response in patients with COVID-19 |
|
| Vol 33, No 2 (2022) |
Articles |
Bacteriophages: past, present, future |
|
| Vol 33, No 3 (2022) |
Articles |
ANTIBACTERIAL PROPERTIES OF THE CHEMOKINE CXCL9 |
|
| Vol 33, No 10 (2022) |
Articles |
COVID-19: pathogenetic aspects |
|
| Vol 34, No 1 (2023) |
From Practice |
The evolution of the use of bacteriophages in the practice of treating infectious diseases |
|
| Vol 34, No 2 (2023) |
From Practice |
Assessment of clinical data and the species composition of pathogens in the upper respiratory tract of patients with COVID-19 and determination of sensitivity to essential etiotropic drugs |
|
| Vol 34, No 4 (2023) |
Problem |
The importance of monitoring viral activity and viral load of SARS-CoV-2 |
|
| Vol 34, No 11 (2023) |
Health Care Service |
A personalized approach to discharge and follow-up of patients with COVID-19 |
|
| Vol 35, No 3 (2024) |
Lecture |
Evaluation of the effectiveness of immunoglobulins in treatment of infectious diseases |
|
| Vol 35, No 8 (2024) |
From Practice |
Differential diagnosis of exanthems in infectious mononucleosis (clinical case) |
|
| Vol 35, No 12 (2024) |
Topical Subject |
Topical issues of respiratory syncytial infection |
|
